Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
S. E. Inzucchi(Yale University), David R. Matthews(Manchester College)
Cited by 3,931
Related Papers
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
|Diabetes Care|2012|3.2k
Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials
|The Lancet Diabetes & Endocrinology|2018|642
Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes
|New England Journal of Medicine|2014|624
Evidence for temporal coupling of growth hormone, prolactin, LH and FSH pulsatility overnight during normal puberty
|Journal of Endocrinology|1991|41